This announcement is a separate document:
基石藥業-B：(1) 建議根據首次公開發售後僱員持股計劃向現有承授人重授購股權；(2) 建議根據首次公開發售後僱員持股計劃向一名董事兼首席執行官授出購股權；(3) 建議修訂首次公開發售後僱員持股計劃；(4) 建議修訂首次公開發售後受限制股份獎勵計劃；(5) 建議採納計劃授權上限；(6) 建議採納服務提供者分項上限；(7) 臨時股東大會通告
CSTONE PHARMA-B: (1) PROPOSED RE-GRANTS OF SHARE OPTIONS TO EXISTING GRANTEES UNDER THE POST-IPO ESOP; (2) PROPOSED GRANT OF SHARE OPTIONS TO A DIRECTOR AND CHIEF EXECUTIVE OFFICER UNDER THE POST-IPO ESOP; (3) PROPOSED AMENDMENTS TO THE POST-IPO ESOP; (4)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.